A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

ישראלמגייס משתתפיםPHASE1

מצבים רפואיים

Heterozygous Familial Hypercholesterolemia · Premature Coronary Heart Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Clinical Study Center, Rehovot, Israel

  • Clinical Study Center, Dothan, Alabama, United States

  • Clinical Study Center, Pomona, California, United States

  • Clinical Study Center, Boca Raton, Florida, United States

  • Clinical Study Center, Jacksonville, Florida, United States

  • Clinical Study Center, Winter Park, Florida, United States

  • Clinical Study Center, High Point, North Carolina, United States

  • Clinical Study Center, DeSoto, Texas, United States

  • Clinical Study Center, Renton, Washington, United States

  • Clinical Study Center, Adelaide, Australia

  • Clinical Study Center, Melbourne, Australia

  • Clinical Study Center, Sydney, Australia

  • Clinical Study Center, Chicoutimi, Canada

  • Clinical Study Center, Hamilton, Canada

  • Clinical Study Center, Montreal, Canada

  • Clinical Study Center, Québec, Canada

  • Clinical Study Center, Toronto, Canada

  • Clinical Study Center, Vancouver, Canada

  • Clinical Study Center, Christchurch, New Zealand

  • Clinical Study Center, Birmingham, United Kingdom

  • Clinical Study Center, Edinburgh, United Kingdom

  • Clinical Study Center, London, United Kingdom

  • Clinical Study Center, Manchester, United Kingdom

  • Clinical Study Center, Nottingham, United Kingdom

מובילי המחקר
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company